DIN 02139545 — POTASSIUM PHOSPHATES INJECTION, USP 224 MG; 236 MG
POTASSIUM PHOSPHATES INJECTION, USP is a solution of Potassium Phosphate Dibasic / Potassium Phosphate Monobasic marketed by FRESENIUS KABI CANADA LTD. The full Potassium Phosphate Dibasic / Potassium Phosphate Monobasic monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02139545
- Brand name
- POTASSIUM PHOSPHATES INJECTION, USP
- Active ingredient
- Potassium Phosphate Dibasic / Potassium Phosphate Monobasic
- Strength
- 224 MG; 236 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- FRESENIUS KABI CANADA LTD
- Health Canada status
- MARKETED
- Drug class
- Electrolyte replenisher (potassium and phosphate salt combination for IV use)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Potassium Phosphate Dibasic / Potassium Phosphate Monobasic products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00804789 | POTASSIUM PHOSPHATES | 224 MG; 236 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED |